Welsis (WLSS) Return on Capital Employed (2022 - 2025)

Name: Welsis (WLSS) Return on Capital Employed (2022 - 2025) | Business Quant
Creator: Business Quant

Welsis' quarterly Return on Capital Employed came in at 43.14% in Q4 2025, down 29.68% quarter-over-quarter from 61.35% in Q3 2025.

Welsis has reported Return on Capital Employed for 4 years, with the latest figure at 43.14% in Q4 2025.

For the quarter ending Q4 2025, Return on Capital Employed changed N/A year-over-year to 43.14%; the trailing twelve-month figure through Dec 2025 stood at 43.14% (changed N/A YoY), and the FY2023 full-year result was 33.84%, down 6741.0% from the prior year.
Return on Capital Employed for Q4 2025 stood at 43.14%, down from 61.35% in the prior quarter.
The five-year high for Return on Capital Employed was 1093.73% in Q2 2024, with the low at 824.06% in Q1 2024.
Average Return on Capital Employed over 4 years is 81.29%, with a median of 74.59% recorded in 2023.
Year-over-year, Return on Capital Employed jumped 102135 bps in 2024 and sank 101692 bps in 2025.
Tracing WLSS's Return on Capital Employed over 4 years: stood at 92.97% in 2022, then tumbled by 49 bps to 47.81% in 2023, then surged by 2187 bps to 1093.73% in 2024, then sank by 96 bps to 43.14% in 2025.
The last three Return on Capital Employed figures came in at 43.14% (Q4 2025), 61.35% (Q3 2025), and 76.81% (Q2 2025), per Business Quant data.

Peer Comparison

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	ROCE (Qtr)
1	Veeva Systems	30.85 Bn	24.28 Bn	622.47 Mn	13.28%
2	BrightSpring Health Services	12.29 Bn	11.41 Bn	482.22 Mn	2.09%
3	Healthequity	7.80 Bn	7.48 Bn	256.31 Mn	10.67%
4	Hinge Health	4.82 Bn	4.51 Bn	154.23 Mn	-163.65%
5	Doximity	4.21 Bn	3.46 Bn	125.97 Mn	21.81%
6	Waystar Holding	4.18 Bn	4.03 Bn	268.04 Mn	4.73%
7	10x Genomics	3.78 Bn	3.24 Bn	106.18 Mn	-4.23%
8	Privia Health	2.65 Bn	2.28 Bn	595.71 Mn	4.60%
9	Omnicell	1.95 Bn	1.78 Bn	140.36 Mn	2.23%
10	Welsis	-	-	-	43.14%

Download Data 🔒